These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder. DeVeaugh-Geiss J; Landau P; Katz R Psychopharmacol Bull; 1989; 25(1):36-40. PubMed ID: 2672070 [TBL] [Abstract][Full Text] [Related]
6. A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder. Pigott TA; Pato MT; L'Heureux F; Hill JL; Grover GN; Bernstein SE; Murphy DL J Clin Psychopharmacol; 1991 Aug; 11(4):242-8. PubMed ID: 1918422 [TBL] [Abstract][Full Text] [Related]
7. Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders. Amin MM; Ban TA; Pecknold JC; Klingner A J Int Med Res; 1977; 5 Suppl 5():33-7. PubMed ID: 340305 [TBL] [Abstract][Full Text] [Related]
8. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291 [TBL] [Abstract][Full Text] [Related]
9. Obsessive-compulsive disorder. Insel TR Psychiatr Clin North Am; 1985 Mar; 8(1):105-17. PubMed ID: 3887336 [TBL] [Abstract][Full Text] [Related]
10. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246 [TBL] [Abstract][Full Text] [Related]
11. Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents. Murphy DL; Pato MT; Pigott TA J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):91S-100S. PubMed ID: 1973944 [TBL] [Abstract][Full Text] [Related]
12. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients. Pato MT; Hill JL; Murphy DL Psychopharmacol Bull; 1990; 26(2):211-4. PubMed ID: 2236458 [TBL] [Abstract][Full Text] [Related]
13. An integrated approach to treatment of obsessive compulsive disorder. Greist JH J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963 [TBL] [Abstract][Full Text] [Related]
14. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine. Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655 [TBL] [Abstract][Full Text] [Related]
15. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels. Mavissakalian MR; Jones B; Olson S; Perel JM J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699 [TBL] [Abstract][Full Text] [Related]
16. Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil). Ananth J J Int Med Res; 1977; 5 Suppl 5():38-41. PubMed ID: 598604 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of obsessive-compulsive disorder. Jermain DM; Crismon ML Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535 [TBL] [Abstract][Full Text] [Related]
18. Tourette's syndrome and treatment with clomipramine hydrochloride. Donahoe DH; Meador M; Fortune T; Llorena R W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522 [TBL] [Abstract][Full Text] [Related]